A 25-year-old medical student has recently completed a clinical placement in a respiratory ward. One of the patients she clerked has subsequently been diagnosed with smear-positive pulmonary tuberculosis. The student is asymptomatic with a normal chest X-ray. Her Mantoux test performed 2 years ago as part of pre-university screening was 3 mm. A new Mantoux test now shows 18 mm induration. What is the most appropriate interpretation and management?
Q212
A 45-year-old man with known pulmonary tuberculosis has been on treatment with rifampicin, isoniazid, pyrazinamide, and ethambutol for 6 weeks. He presents to his GP with painless visual impairment and reduced colour vision, particularly difficulty distinguishing red from green. Visual acuity testing shows bilateral reduction. What is the most appropriate immediate action?
Q213
A 33-year-old woman from Romania presents with a 2-month history of productive cough, fever, and weight loss. Chest X-ray shows right upper lobe cavitation with bilateral nodular infiltrates. Sputum microscopy shows acid-fast bacilli. GeneXpert MTB/RIF assay detects Mycobacterium tuberculosis with rifampicin resistance. Culture subsequently confirms multidrug-resistant TB with resistance to rifampicin and isoniazid, but sensitivity to fluoroquinolones and second-line injectables. What is the minimum recommended treatment duration for this patient?
Q214
A 70-year-old man with type 2 diabetes mellitus presents with a 3-day history of fever, confusion, and neck stiffness. Lumbar puncture shows: opening pressure 28 cmH₂O, CSF glucose 1.8 mmol/L (serum glucose 8.2 mmol/L), protein 2.4 g/L, white cells 850/mm³ (95% polymorphs), Gram stain shows Gram-positive diplococci. He is started on intravenous ceftriaxone 2 g twice daily and dexamethasone. What additional antibiotic should be added to his regimen?
Q215
A 4-year-old boy is brought to the emergency department with a 5-hour history of fever, vomiting, drowsiness, and photophobia. On examination, he has a temperature of 39.5°C, Glasgow Coma Scale score of 13, and a petechial rash on his lower limbs. Lumbar puncture is performed. While awaiting CSF results, blood tests show: WBC 18.2 × 10⁹/L, neutrophils 15.4 × 10⁹/L, CRP 156 mg/L, procalcitonin 8.2 ng/mL. Which additional immediate management should be considered alongside antibiotic therapy?
Q216
A 42-year-old homeless man with a history of alcohol dependency presents with a 6-week history of cough, weight loss, and night sweats. Chest X-ray shows bilateral upper zone cavitation. Sputum samples are positive for acid-fast bacilli on microscopy. He is commenced on standard quadruple anti-tuberculosis therapy. On day 5 of treatment, he reports tingling and numbness in his feet. Which medication should have been prescribed prophylactically to prevent this complication?
Q217
A 26-year-old man presents to the emergency department with a 6-hour history of severe headache, fever of 39.2°C, neck stiffness, and a non-blanching purpuric rash on his trunk and limbs. Blood cultures are taken and empirical antibiotic therapy is commenced immediately. Which antibiotic regimen should be administered first-line in this scenario?
Q218
A 35-year-old woman with pulmonary tuberculosis is being treated with rifampicin, isoniazid, pyrazinamide, and ethambutol. She takes the combined oral contraceptive pill for contraception. What is the most appropriate advice regarding her contraception during tuberculosis treatment?
Q219
A 17-year-old student presents with a 10-hour history of fever, headache, photophobia, and a non-blanching rash. She is given IM benzylpenicillin by the GP and transferred to hospital. On arrival, she is alert, GCS 15, temperature 38.5°C, heart rate 105/min, blood pressure 110/70 mmHg. Blood cultures are taken. Lumbar puncture shows: white cell count 2,800/mm³ (92% neutrophils), protein 2.2 g/L, glucose 2.8 mmol/L. Gram stain shows no organisms. PCR is pending. What is the most appropriate immediate antibiotic treatment?
Q220
A 31-year-old man with CD4 count 50 cells/mm³ presents with headache, fever, and confusion over 2 weeks. MRI shows meningeal enhancement. Lumbar puncture reveals opening pressure 32 cmH2O, white cell count 45/mm³ (90% lymphocytes), protein 1.1 g/L, glucose 2.0 mmol/L (plasma glucose 5.5 mmol/L). India ink stain is positive. Cryptococcal antigen titre is 1:2048. He is started on liposomal amphotericin B and flucytosine. What is the most important additional management to improve outcomes?
Serious & Notifiable Infections UK Medical PG Practice Questions and MCQs
Question 211: A 25-year-old medical student has recently completed a clinical placement in a respiratory ward. One of the patients she clerked has subsequently been diagnosed with smear-positive pulmonary tuberculosis. The student is asymptomatic with a normal chest X-ray. Her Mantoux test performed 2 years ago as part of pre-university screening was 3 mm. A new Mantoux test now shows 18 mm induration. What is the most appropriate interpretation and management?
A. This represents a false positive result; no action required as she is asymptomatic
B. This represents latent TB infection requiring isoniazid chemoprophylaxis for 6 months (Correct Answer)
C. This represents recent BCG vaccination effect; repeat testing in 6 weeks
D. This represents active TB disease requiring full four-drug anti-tuberculosis therapy
E. This indicates tuberculin conversion; commence rifampicin and isoniazid for 3 months
Explanation: ***This represents latent TB infection requiring isoniazid chemoprophylaxis for 6 months*** - A **tuberculin conversion** from 3 mm to 18 mm after recent exposure to a **smear-positive pulmonary tuberculosis** patient strongly indicates recent acquisition of **latent TB infection (LTBI)**. - For healthcare workers with recent LTBI, **isoniazid chemoprophylaxis for 6-9 months** is the standard treatment to prevent progression to active TB disease. *This represents a false positive result; no action required as she is asymptomatic* - An induration of **18 mm** following significant exposure is a **strongly positive** Mantoux test result, not a false positive, especially given the prior 3 mm reading. - While asymptomatic, individuals with LTBI still carry a significant **lifetime risk of reactivating** to active disease, making treatment crucial. *This represents recent BCG vaccination effect; repeat testing in 6 weeks* - The previous Mantoux result of 3 mm suggests that any prior **BCG vaccination effect** was minimal or had waned, making a subsequent 18 mm induration indicative of **true infection** after exposure, not a vaccine effect. - Repeating the test is unnecessary as the **tuberculin conversion** is already clear, and delay would increase the risk of disease progression. *This represents active TB disease requiring full four-drug anti-tuberculosis therapy* - The student is **asymptomatic** and has a **normal chest X-ray**, which effectively rules out **active pulmonary tuberculosis**. - **Full four-drug anti-tuberculosis therapy** is reserved for confirmed or highly suspected active disease, not for asymptomatic latent infection. *This indicates tuberculin conversion; commence rifampicin and isoniazid for 3 months* - While this option correctly identifies **tuberculin conversion** and proposes a valid **LTBI treatment regimen** (rifampicin and isoniazid for 3 months), the 6-month isoniazid regimen is often considered the more widely accepted and commonly practiced **first-line chemoprophylaxis** for recent converters in many guidelines.
Question 212: A 45-year-old man with known pulmonary tuberculosis has been on treatment with rifampicin, isoniazid, pyrazinamide, and ethambutol for 6 weeks. He presents to his GP with painless visual impairment and reduced colour vision, particularly difficulty distinguishing red from green. Visual acuity testing shows bilateral reduction. What is the most appropriate immediate action?
A. Continue all medications and reassure that this will resolve after completing treatment
B. Stop ethambutol immediately and arrange urgent ophthalmology review (Correct Answer)
C. Stop rifampicin immediately and arrange liver function tests
D. Stop isoniazid immediately and commence high-dose pyridoxine
E. Reduce the dose of all anti-tuberculosis medications by 50%
Explanation: ***Stop ethambutol immediately and arrange urgent ophthalmology review***
- The patient's symptoms of **painless visual impairment**, **reduced visual acuity**, and specific difficulty with **red-green colour discrimination** are hallmark signs of **ethambutol-induced optic neuropathy**.
- Immediate cessation of ethambutol is crucial to prevent **irreversible vision loss**, and an urgent ophthalmology review is necessary to assess the severity and guide further management.
*Continue all medications and reassure that this will resolve after completing treatment*
- Continuing **ethambutol** despite ocular symptoms risks progression to **permanent blindness** as the damage can be irreversible if not detected and managed promptly.
- Reassurance without action is inappropriate; **ethambutol-induced optic neuropathy** requires immediate medical intervention, not just waiting for treatment completion.
*Stop rifampicin immediately and arrange liver function tests*
- **Rifampicin** is associated with **hepatotoxicity** (elevated liver enzymes, jaundice) and harmless **orange discoloration** of bodily fluids, not visual impairment or optic neuropathy.
- While liver function monitoring is standard with rifampicin, it is unrelated to the patient's specific **ocular symptoms**.
*Stop isoniazid immediately and commence high-dose pyridoxine*
- **Isoniazid** is known to cause **peripheral neuropathy**, which is often mitigated by co-administration of **pyridoxine (vitamin B6)**.
- It is not the cause of **optic neuropathy** with red-green colour vision deficits, making this action incorrect for the presenting visual symptoms.
*Reduce the dose of all anti-tuberculosis medications by 50%*
- Reducing doses of all drugs without identifying the specific causative agent is not a standard approach and risks **treatment failure** and the development of **drug resistance**.
- The correct action for drug toxicity involves identifying and stopping the offending agent, not broadly reducing all medication doses.
Question 213: A 33-year-old woman from Romania presents with a 2-month history of productive cough, fever, and weight loss. Chest X-ray shows right upper lobe cavitation with bilateral nodular infiltrates. Sputum microscopy shows acid-fast bacilli. GeneXpert MTB/RIF assay detects Mycobacterium tuberculosis with rifampicin resistance. Culture subsequently confirms multidrug-resistant TB with resistance to rifampicin and isoniazid, but sensitivity to fluoroquinolones and second-line injectables. What is the minimum recommended treatment duration for this patient?
A. 6 months
B. 9 months
C. 12 months
D. 18 months (Correct Answer)
E. 24 months
Explanation: ***18 months***
- For **Multidrug-resistant TB (MDR-TB)**, which is resistant to both **isoniazid** and **rifampicin**, the standard recommendation for conventional longer regimens is a minimum duration of **18 to 20 months**.
- This prolonged course is essential due to the reduced potency of second-line drugs and the presence of **cavitation**, requiring treatment for at least **15-18 months after culture conversion**.
*6 months*
- This is the standard duration for **drug-sensitive TB**, utilizing the **RIPE** regimen (Rifampicin, Isoniazid, Pyrazinamide, Ethambutol).
- It is entirely insufficient for **MDR-TB** where the core first-line bactericidal drugs, rifampicin and isoniazid, are ineffective.
*9 months*
- Shorter MDR-TB regimens (9-12 months) are reserved for carefully selected patients, typically without **cavitation** and with no prior exposure to second-line drugs or additional resistance.
- Given the presence of **cavitation** and confirmed MDR-TB, a 9-month course would be inadequate and increase the risk of treatment failure.
*12 months*
- A **12-month** regimen does not meet the current **WHO guidelines** for the management of confirmed MDR-TB, especially in cases with **cavitation**.
- Inadequate treatment duration significantly increases the risk of **relapse** and the potential development of more extensively drug-resistant forms of TB.
*24 months*
- While some highly complex cases, such as those with **extensive lung damage** or **extensively drug-resistant TB (XDR-TB)**, may require treatment up to 24 months, this is not the **minimum** recommended duration for the described MDR-TB.
- The goal for conventional longer MDR-TB regimens is typically completion by **18-20 months** based on current guidelines.
Question 214: A 70-year-old man with type 2 diabetes mellitus presents with a 3-day history of fever, confusion, and neck stiffness. Lumbar puncture shows: opening pressure 28 cmH₂O, CSF glucose 1.8 mmol/L (serum glucose 8.2 mmol/L), protein 2.4 g/L, white cells 850/mm³ (95% polymorphs), Gram stain shows Gram-positive diplococci. He is started on intravenous ceftriaxone 2 g twice daily and dexamethasone. What additional antibiotic should be added to his regimen?
A. Intravenous amoxicillin 2 g four-hourly
B. Intravenous vancomycin 1 g twice daily (Correct Answer)
C. Intravenous metronidazole 500 mg three times daily
D. Intravenous gentamicin 5 mg/kg once daily
E. Intravenous meropenem 2 g three times daily
Explanation: ***Intravenous vancomycin 1 g twice daily***
- Gram-positive diplococci on Gram stain identifies **Streptococcus pneumoniae**, which often exhibits **penicillin resistance**; adding **vancomycin** provides essential coverage for resistant strains until sensitivities are known.
- In patients over **50 years** or with comorbidities like **diabetes**, empirical therapy for meningitis requires dual coverage with **ceftriaxone** and **vancomycin** to ensure bactericidal activity against pneumococcus.
*Intravenous amoxicillin 2 g four-hourly*
- **Amoxicillin** is typically added to cover **Listeria monocytogenes** in elderly or immunocompromised patients, but this organism appears as **Gram-positive bacilli**, not diplococci.
- While the patient's age and diabetes are risk factors for Listeria, the Gram stain specifically points toward pneumococcus, making vancomycin the prioritized addition for **resistance coverage**.
*Intravenous metronidazole 500 mg three times daily*
- This agent provides coverage against **anaerobes**, which are generally associated with **brain abscesses** or infections secondary to chronic ear/sinus disease rather than acute bacterial meningitis.
- It has no clinical utility in the treatment of **Streptococcus pneumoniae** or other common causes of community-acquired meningitis.
*Intravenous gentamicin 5 mg/kg once daily*
- **Aminoglycosides** like gentamicin have very **poor penetration** across the blood-brain barrier into the **cerebrospinal fluid (CSF)**, even when the meninges are inflamed.
- They are typically used for synergy in certain endocarditis cases or for specific **Gram-negative** infections but are not standard for pneumococcal meningitis.
*Intravenous meropenem 2 g three times daily*
- While a broad-spectrum carbapenem, **meropenem** is usually reserved for patients with severe **beta-lactam allergies** or those with highly resistant Gram-negative organisms.
- Using it as an add-on to ceftriaxone for Gram-positive diplococci is unnecessary and does not align with standard **antimicrobial stewardship** guidelines for bacterial meningitis.
Question 215: A 4-year-old boy is brought to the emergency department with a 5-hour history of fever, vomiting, drowsiness, and photophobia. On examination, he has a temperature of 39.5°C, Glasgow Coma Scale score of 13, and a petechial rash on his lower limbs. Lumbar puncture is performed. While awaiting CSF results, blood tests show: WBC 18.2 × 10⁹/L, neutrophils 15.4 × 10⁹/L, CRP 156 mg/L, procalcitonin 8.2 ng/mL. Which additional immediate management should be considered alongside antibiotic therapy?
A. Intravenous aciclovir 10 mg/kg three times daily
B. Intravenous dexamethasone 0.15 mg/kg four times daily for 4 days (Correct Answer)
C. Oral prednisolone 2 mg/kg once daily for 5 days
D. Intravenous immunoglobulin 2 g/kg as a single dose
E. Intrathecal gentamicin 5 mg once daily
Explanation: ***Intravenous dexamethasone 0.15 mg/kg four times daily for 4 days***
- Adjunctive **dexamethasone** is recommended in children older than 3 months with suspected **bacterial meningitis** to reduce the inflammatory response in the subarachnoid space.
- Evidence shows it significantly reduces the risk of **neurological sequelae**, especially **hearing loss**, and should ideally be administered shortly before or with the first dose of antibiotics.
*Intravenous aciclovir 10 mg/kg three times daily*
- This treatment is used for **HSV encephalitis**, which usually presents with **focal neurological deficits** or seizures rather than a petechial rash.
- The markedly elevated **CRP (156 mg/L)** and **procalcitonin** strongly favor a bacterial etiology over a viral one.
*Oral prednisolone 2 mg/kg once daily for 5 days*
- **Oral administration** is inappropriate in an acutely unwell child with a reduced **Glasgow Coma Scale** score and vomiting.
- Standard protocols for meningitis require the specific dosing of **intravenous dexamethasone** to achieve rapid, reliable anti-inflammatory effects in the CNS.
*Intravenous immunoglobulin 2 g/kg as a single dose*
- **IVIG** is used in conditions like **Kawasaki disease** or ITP, but it has no established role in the routine management of acute bacterial meningitis.
- It does not address the primary pathophysiology of **bacterial toxin release** and meningeal inflammation following antibiotic administration.
*Intrathecal gentamicin 5 mg once daily*
- **Intrathecal antibiotics** are not standard practice for community-acquired meningitis and carry risks of neurotoxicity and secondary infection.
- Systemic high-dose **third-generation cephalosporins** (like ceftriaxone) provide adequate CSF penetration for most causative organisms like *N. meningitidis*.
Question 216: A 42-year-old homeless man with a history of alcohol dependency presents with a 6-week history of cough, weight loss, and night sweats. Chest X-ray shows bilateral upper zone cavitation. Sputum samples are positive for acid-fast bacilli on microscopy. He is commenced on standard quadruple anti-tuberculosis therapy. On day 5 of treatment, he reports tingling and numbness in his feet. Which medication should have been prescribed prophylactically to prevent this complication?
A. Thiamine 100 mg daily
B. Folic acid 5 mg daily
C. Pyridoxine 10 mg daily (Correct Answer)
D. Vitamin B12 1 mg intramuscularly monthly
E. Vitamin D 800 IU daily
Explanation: ***Pyridoxine 10 mg daily***
- Isoniazid, a key component of quadruple anti-tuberculosis therapy, inhibits the activation of **Vitamin B6 (Pyridoxine)**, leading to a drug-induced **peripheral neuropathy**.
- Prophylaxis is mandatory for high-risk patients, including those with **alcohol dependency**, malnutrition, diabetes, or pregnancy, to prevent the tingling and numbness (paresthesia) observed here.
*Thiamine 100 mg daily*
- While essential in patients with alcohol dependency to prevent **Wernicke-Korsakoff syndrome**, it does not mitigate the neurotoxic effects of isoniazid.
- Thiamine deficiency typically presents with **ataxia**, ophthalmoplegia, and confusion rather than isolated sensory neuropathy shortly after starting TB treatment.
*Folic acid 5 mg daily*
- Folic acid is primarily used to prevent **megaloblastic anemia** and neural tube defects; it is not depleted by standard anti-tuberculosis medications.
- It is frequently co-administered with **methotrexate** in rheumatology but has no role in preventing isoniazid-induced side effects.
*Vitamin B12 1 mg intramuscularly monthly*
- Vitamin B12 deficiency causes **Subacute Combined Degeneration** of the spinal cord, characterized by loss of vibration and position sense.
- While alcoholics may be malnourished, B12 does not interact with **isoniazid metabolism**, and its deficiency takes much longer than 5 days to manifest as new neurological symptoms.
*Vitamin D 800 IU daily*
- Vitamin D is vital for **bone health** and calcium homeostasis, especially in patients with poor sunlight exposure or malnutrition.
- It does not provide protection against **nerve conduction** defects or the pyridoxine-depleting mechanisms of anti-TB drugs.
Question 217: A 26-year-old man presents to the emergency department with a 6-hour history of severe headache, fever of 39.2°C, neck stiffness, and a non-blanching purpuric rash on his trunk and limbs. Blood cultures are taken and empirical antibiotic therapy is commenced immediately. Which antibiotic regimen should be administered first-line in this scenario?
A. Intravenous benzylpenicillin 2.4 g four times daily
B. Intravenous ceftriaxone 2 g twice daily (Correct Answer)
C. Intravenous vancomycin 1 g twice daily plus ceftriaxone 2 g twice daily
D. Intravenous meropenem 2 g three times daily
E. Intramuscular benzylpenicillin 1.2 g single dose
Explanation: ***Intravenous ceftriaxone 2 g twice daily***- In a patient presenting with classic signs of **bacterial meningitis** and a **purpuric rash** (highly suggestive of **meningococcal disease**), **intravenous ceftriaxone** is the first-line empirical antibiotic due to its excellent **CSF penetration** and broad spectrum against *Neisseria meningitidis* and *Streptococcus pneumoniae*.- This regimen is well-established as the standard of care for empirical treatment of community-acquired bacterial meningitis in young adults, providing rapid and effective coverage.*Intravenous benzylpenicillin 2.4 g four times daily*- While effective against *Neisseria meningitidis*, **benzylpenicillin** has a narrower spectrum and may not adequately cover increasingly common **penicillin-resistant *Streptococcus pneumoniae***, which is a major concern in empirical meningitis therapy.- It is therefore not recommended as a first-line single agent for empirical treatment in the hospital setting where broader coverage is often required.*Intravenous vancomycin 1 g twice daily plus ceftriaxone 2 g twice daily*- This combination is typically reserved for situations where there is a high suspicion of **highly resistant *Streptococcus pneumoniae***, such as in immunocompromised patients, those with recent severe antibiotic exposure, or in regions with high rates of penicillin-resistant pneumococci.- For a previously healthy young adult presenting with suspected meningitis, **ceftriaxone monotherapy** is generally sufficient as initial empirical treatment unless specific risk factors for resistant organisms are present.*Intravenous meropenem 2 g three times daily*- **Meropenem** is a broad-spectrum carbapenem often reserved for treating **multi-drug resistant (MDR)** bacterial infections, severe beta-lactam allergies, or specific pathogens like *Listeria* (in older or immunocompromised patients).- Using such a broad-spectrum antibiotic as first-line in this scenario is generally not recommended due to concerns about **antimicrobial stewardship** and promoting resistance.*Intramuscular benzylpenicillin 1.2 g single dose*- This is the recommended **pre-hospital** empirical treatment for suspected meningococcal disease with a purpuric rash, administered by general practitioners or paramedics to provide immediate coverage before hospital transfer.- Once the patient reaches the emergency department, definitive **intravenous antibiotic therapy** with a drug like ceftriaxone should be initiated, rather than a single intramuscular dose.
Question 218: A 35-year-old woman with pulmonary tuberculosis is being treated with rifampicin, isoniazid, pyrazinamide, and ethambutol. She takes the combined oral contraceptive pill for contraception. What is the most appropriate advice regarding her contraception during tuberculosis treatment?
A. Continue the combined oral contraceptive pill as rifampicin does not affect its efficacy
B. Switch to a progesterone-only pill as this is not affected by rifampicin
C. Use additional barrier contraception or switch to a non-hormonal method (Correct Answer)
D. Double the dose of the combined oral contraceptive pill
E. Stop all contraception as tuberculosis medications cause temporary infertility
Explanation: ***Use additional barrier contraception or switch to a non-hormonal method***
- **Rifampicin** is a potent inducer of hepatic **cytochrome P450 enzymes**, which significantly increases the metabolism and reduces the efficacy of hormonal contraceptives, including the combined oral contraceptive pill.
- Current guidelines recommend using **barrier methods** (like condoms) or non-hormonal options (such as the **copper intrauterine device [IUD]**) to prevent unintended pregnancy during treatment and for several weeks after cessation of rifampicin.
*Continue the combined oral contraceptive pill as rifampicin does not affect its efficacy*
- This statement is incorrect because **rifampicin** significantly reduces the serum concentrations of both **estrogen** and **progestogen** components of the combined oral contraceptive pill, leading to contraceptive failure.
- Continuing the pill without additional measures puts the patient at high risk of **unwanted pregnancy**, which is particularly concerning while taking potentially teratogenic or hepatotoxic medications.
*Switch to a progesterone-only pill as this is not affected by rifampicin*
- The **progesterone-only pill (POP)** is also metabolized by the liver enzymes induced by **rifampicin**.
- Its effectiveness is severely compromised by this **enzyme induction**, making it an unreliable sole method of contraception in this clinical scenario.
*Double the dose of the combined oral contraceptive pill*
- **Doubling the dose** of the combined oral contraceptive pill is generally no longer recommended due to variable individual responses to **enzyme induction** and potential for increased **side effects** without guaranteed contraceptive efficacy.
- High-dose hormonal regimens increase the risk of adverse effects like **venous thromboembolism** without ensuring adequate contraceptive protection against rifampicin's effects.
*Stop all contraception as tuberculosis medications cause temporary infertility*
- **Tuberculosis medications**, including rifampicin and isoniazid, do not cause **infertility**; patients remain fertile throughout their treatment.
- It is crucial to maintain effective contraception as pregnancy during multidrug therapy for tuberculosis requires specialized monitoring and careful consideration of drug safety.
Question 219: A 17-year-old student presents with a 10-hour history of fever, headache, photophobia, and a non-blanching rash. She is given IM benzylpenicillin by the GP and transferred to hospital. On arrival, she is alert, GCS 15, temperature 38.5°C, heart rate 105/min, blood pressure 110/70 mmHg. Blood cultures are taken. Lumbar puncture shows: white cell count 2,800/mm³ (92% neutrophils), protein 2.2 g/L, glucose 2.8 mmol/L. Gram stain shows no organisms. PCR is pending. What is the most appropriate immediate antibiotic treatment?
A. Continue with benzylpenicillin alone as already administered
B. Intravenous ceftriaxone 2g twice daily
C. Intravenous ceftriaxone and dexamethasone (Correct Answer)
D. Intravenous ceftriaxone, vancomycin, and aciclovir
E. Intravenous meropenem and vancomycin
Explanation: ***Intravenous ceftriaxone and dexamethasone***
- The clinical presentation (fever, headache, photophobia, non-blanching rash) and CSF findings (high white cell count with neutrophil predominance, elevated protein, low glucose) are highly suggestive of **bacterial meningitis**. **Intravenous ceftriaxone** is the recommended empirical antibiotic for this age group.
- Adjunctive **dexamethasone** is crucial in bacterial meningitis to reduce inflammation and the risk of **neurological complications** such as hearing loss, especially when **pneumococcal meningitis** is suspected, and should be given with or just before the first dose of antibiotics.
*Continue with benzylpenicillin alone as already administered*
- Pre-hospital **intramuscular benzylpenicillin** is a critical initial measure for suspected meningococcal disease with a non-blanching rash, aiming to stabilize the patient, but it is not sufficient for definitive hospital treatment of bacterial meningitis.
- For confirmed or highly suspected bacterial meningitis, a **third-generation cephalosporin** like ceftriaxone provides broader coverage, superior CSF penetration, and is the standard of care for optimal outcomes.
*Intravenous ceftriaxone 2g twice daily*
- While **intravenous ceftriaxone** is the correct antibiotic choice for empirical treatment of bacterial meningitis, this option is incomplete as it omits the vital adjunctive **dexamethasone** therapy.
- Omitting **dexamethasone** in bacterial meningitis management can lead to poorer outcomes, including a higher incidence of **sensorineural hearing loss** and other focal neurological deficits, as per current guidelines.
*Intravenous ceftriaxone, vancomycin, and aciclovir*
- **Aciclovir** is indicated for suspected **viral encephalitis** (e.g., HSV encephalitis), which typically presents with altered consciousness, focal neurological signs, or seizures, not primarily a non-blanching rash and classic bacterial CSF picture.
- **Vancomycin** is generally added empirically only in areas with high rates of **penicillin-resistant *S. pneumoniae*** or in specific high-risk groups (e.g., immunocompromised, recent neurosurgery), which is not routinely indicated in this patient's initial presentation.
*Intravenous meropenem and vancomycin*
- **Meropenem** is a carbapenem, a broad-spectrum antibiotic, usually reserved for patients with severe **beta-lactam allergy**, suspected **multi-drug resistant organisms**, or in very severe, complicated cases, which is not the initial empirical choice for an immunocompetent teenager.
- This combination represents a very broad-spectrum approach that is typically reserved for more complex or resistant infections and is not the first-line empirical regimen for suspected bacterial meningitis in an otherwise healthy 17-year-old.
Question 220: A 31-year-old man with CD4 count 50 cells/mm³ presents with headache, fever, and confusion over 2 weeks. MRI shows meningeal enhancement. Lumbar puncture reveals opening pressure 32 cmH2O, white cell count 45/mm³ (90% lymphocytes), protein 1.1 g/L, glucose 2.0 mmol/L (plasma glucose 5.5 mmol/L). India ink stain is positive. Cryptococcal antigen titre is 1:2048. He is started on liposomal amphotericin B and flucytosine. What is the most important additional management to improve outcomes?
A. Add dexamethasone 8 mg four times daily
B. Perform therapeutic lumbar puncture to reduce CSF pressure to <20 cmH2O (Correct Answer)
C. Commence antiretroviral therapy within 72 hours of diagnosis
D. Add rifampicin to enhance antifungal activity
E. Administer intravenous mannitol to reduce intracranial pressure
Explanation: ***Perform therapeutic lumbar puncture to reduce CSF pressure to <20 cmH2O***- This patient has **cryptococcal meningitis** with severely **raised intracranial pressure** (opening pressure 32 cmH2O); aggressive management of pressure is vital for reducing mortality.- Serial **lumbar punctures** are indicated if the opening pressure is >25 cmH2O to prevent neurological complications like vision loss and cranial nerve palsies.*Add dexamethasone 8 mg four times daily*- High-dose **corticosteroids** are specifically **contraindicated** in HIV-associated cryptococcal meningitis as they increase mortality and decrease fungal clearance.- Unlike bacterial meningitis, steroids do not provide a benefit in preventing inflammatory damage in this fungal infection.*Commence antiretroviral therapy within 72 hours of diagnosis*- **ART initiation** should be delayed for at least **4 to 6 weeks** after starting antifungal therapy to prevent **Immune Reconstitution Inflammatory Syndrome (IRIS)**.- Early ART in cryptococcal meningitis is associated with significantly **higher mortality** compared to delayed initiation.*Add rifampicin to enhance antifungal activity*- **Rifampicin** has no role in the treatment of cryptococcosis and may actually lead to drug-drug interactions, such as lowering **fluconazole** levels.- It is primarily used in the treatment of **tuberculosis**, not fungal infections of the central nervous system.*Administer intravenous mannitol to reduce intracranial pressure*- **Mannitol** and other osmotic diuretics are not recommended for the long-term management of raised ICP in **cryptococcal meningitis**.- The elevated pressure is caused by **impaired CSF outflow** due to fungal polysaccharide load, which is best managed by physical **drainage of CSF**.
